Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Brain Stimulation to Treat Blepharospasm or Meige Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating brain stimulation to treat blepharospasm and Meige syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Blepharospasm, Focal Dystonia | Phase 2 | Status: COMPLETED